Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Teicoplan and vancomycin regimens cost-similar in febrile neutropenia

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Teicoplan and vancomycin regimens cost-similar in febrile neutropenia. Pharmacoecon. Outcomes News 203, 8 (1999). https://doi.org/10.1007/BF03295028

    Download citation

    Keywords

    • Vancomycin
    • Adia International Limited
    • Febrile Neutropenia
    • Ceftazidime
    • Amikacin